DOI: 10.4103/0253-7613.93857, Majeed, M., Mundkur, L., Paulose, S., & Nagabhushanam, K
Individual responses vary considerably, with more pronounced effects observed in patients with obesity and baseline hypertension
Conclusion For patients experiencing weight regain after bariatric surgery, two-thirds of the weight regain can be safely lost with GLP1-RA, providing clinicians with a therapeutic option for this clinical challenge, and highlights the need for a large-scale randomized clinical trial
The bone Gla protein osteocalcin, the calcification-inhibiting matrix Gla protein (MGP), the cell growth regulating growth arrest specific gene 6 protein, and the four transmembrane Gla proteins, the function of which is at present unknown
GLP-1RAs, specifically liraglutide, have also been evaluated for their effects on cardiovascular biomarkers